Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This trial will compare 6 versus 12 months of trastuzumab in combination with dose dense docetaxel following FE75C as adjuvant chemotherapy in women with axillary lymph node positive breast cancer overexpressing HER2
Critère d'inclusion
- Breast Cancer